RNA-seq analysis provide new insights into mapk signaling of apolipoproteinciii-induced inflammation in porcine vascular endothelial cells

References

• Galkina E, Ley K Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009;27:165-97. doi:10.1146/annurev.immunol.021908.132620. PMID:19302038
   PubMed Web of Science ®Google Scholar
• Caron S, Staels B Apolipoprotein CIII: a link between hypertriglyceridemia and vascular dysfunction? Circ Res. 2008;103(12):1348-50. doi:10.1161/CIRCRESAHA.108.189860. PMID:19059836
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288(5789):373-6. doi:10.1038/288373a0. PMID:6253831
   PubMed Web of Science ®Google Scholar
• Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, van Gorp EC. Infections and endothelial cells. Cardiovasc Res. 2003;60(1):40-8. doi:10.1016/S0008-6363(03)00354-7. PMID:14522405
   PubMed Web of Science ®Google Scholar
• Wang X, Sun Z, Borjesson A, Andersson R. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. Br J Surg. 1999;86(3):411-6. doi:10.1046/j.1365-2168.1999.01028.x. PMID:10201790
   PubMed Web of Science ®Google Scholar
• Aikawa M, Sugiyama S, Hill CC, Voglic SJ, Rabkin E, Fukumoto Y, Schoen FJ, Witztum JL, Libby P. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation. 2002;106(11):1390-6. doi:10.1161/01.CIR.0000028465.52694.9B. PMID:12221058
   PubMed Web of Science ®Google Scholar
• Brewer HB, Jr., Shulman R, Herbert P, Ronan R, Wehrly K. The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins. J Biol Chem. 1974;249(15):4975-84. PMID:4846755
   PubMed Web of Science ®Google Scholar
• Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol. 1999;19(3):472-84. doi:10.1161/01.ATV.19.3.472. PMID:10073946
   PubMed Web of Science ®Google Scholar
• Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest. 1985;75(2):384-90. doi:10.1172/JCI111711. PMID:3973011
   PubMed Web of Science ®Google Scholar
• Mann CJ, Troussard AA, Yen FT, Hannouche N, Najib J, Fruchart JC, Lotteau V, Andre P, Bihain BE. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. J Biol Chem. 1997;272(50):31348-54. doi:10.1074/jbc.272.50.31348. PMID:9395464
   PubMed Web of Science ®Google Scholar
• Lee SJ, Moye LA, Campos H, Williams GH, Sacks FM. Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease. Atherosclerosis. 2003;167(2):293-302. doi:10.1016/S0021-9150(03)00007-8. PMID:12818412
   PubMed Web of Science ®Google Scholar
• Mendivil CO, Rimm EB, Furtado J, Chiuve SE, Sacks FM. Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. Circulation. 2011;124(19):2065-72. doi:10.1161/CIRCULATIONAHA.111.056986. PMID:21986282
   PubMed Web of Science ®Google Scholar
• Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 1990;249(4970):790-3. doi:10.1126/science.2167514. PMID:2167514
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang Y, Zhu H, Fan J, Yu L, Liu G, Liu E. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII. Transgenic Res. 2011;20(4):867-75. doi:10.1007/s11248-010-9467-5. PMID:21120692
   PubMed Web of Science ®Google Scholar
• Sol EM, Sundsten T, Bergsten P. Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells. Lipids Health Dis. 2009;8:3. doi:10.1186/1476-511X-8-3. PMID:19196457
   PubMed Web of Science ®Google Scholar
• Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation. 2006;114(7):681-7. doi:10.1161/CIRCULATIONAHA.106.622514. PMID:16894036
   PubMed Web of Science ®Google Scholar
• Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM. Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol. 2007;27(1):219-25. doi:10.1161/01.ATV.0000249620.68705.0d. PMID:17038637
   PubMed Web of Science ®Google Scholar
• Feve B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5(6):305-11. doi:10.1038/nrendo.2009.62. PMID:19399017
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265(3):621-361133681. doi:10.1042/bj2650621. PMID:1689567
   PubMed Web of Science ®Google Scholar
• Old LJ Tumor necrosis factor (TNF). Science. 1985;230(4726):630-2. doi:10.1126/science.2413547. PMID:2413547
   PubMed Web of Science ®Google Scholar
• Willms-Kretschmer K, Flax MH, Cotran RS. The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis. Lab Invest. 1967;17(3):334-49. PMID:6051014
   PubMed Web of Science ®Google Scholar
• Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimburger O, Barany P, et al. Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(4):976-85. doi:10.2215/CJN.03960907. PMID:18417746
   PubMed Web of Science ®Google Scholar
• Dubin R, Shlipak M, Li Y, Ix J, de Boer IH, Jenny N, Peralta CA. Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant. 2011;26(6):1903-8. doi:10.1093/ndt/gfq648. PMID:21079193
   PubMed Web of Science ®Google Scholar
• Bear MD, Li M, Liu Y, Giel-Moloney MA, Fanburg BL, Toksoz D. The Lbc Rho guanine nucleotide exchange factor alpha-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation. J Biol Chem. 2010;285(43):32919-26. doi:10.1074/jbc.M109.062513. PMID:20696764
   PubMed Web of Science ®Google Scholar
• Kreiseder B, Holper-Schichl YM, Muellauer B, Jacobi N, Pretsch A, Schmid JA, de Martin R, Hundsberger H, Eger A, Wiesner C. Alpha-catulin contributes to drug-resistance of melanoma by activating NF-kappaB and AP-1. PLoS One. 2015;10(3):e0119402. doi:10.1371/journal.pone.0119402. PMID:25793618
   PubMed Web of Science ®Google Scholar
• Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79(1):143-80. PMID:9922370
   PubMed Web of Science ®Google Scholar
• Fecher LA, Amaravadi RK, Flaherty KT. The MAPK pathway in melanoma. Curr Opin Oncol. 2008;20(2):183-9. doi:10.1097/CCO.0b013e3282f5271c. PMID:18300768
   PubMed Web of Science ®Google Scholar
• Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, Bian LG, Ai QL, Liu YD, Sun J, Lu. D Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One. 2011;6(7):e21891. doi:10.1371/journal.pone.0021891. PMID:21765922
   PubMed Web of Science ®Google Scholar
• Ajmone-Cat MA, De Simone R, Nicolini A, Minghetti L. Effects of phosphatidylserine on p38 mitogen activated protein kinase, cyclic AMP responding element binding protein and nuclear factor-kappaB activation in resting and activated microglial cells. J Neurochem. 2003;84(2):413-6. doi:10.1046/j.1471-4159.2003.01562.x. PMID:12559004
   PubMed Web of Science ®Google Scholar
• Qi M, Elion EA. MAP kinase pathways. J Cell Sci. 2005;118(Pt 16):3569-72. doi: 10.1242/jcs.02470 PMID:16105880
   PubMed Web of Science ®Google Scholar
• Navas TA, Nguyen AN, Hideshima T, Reddy M, Ma JY, Haghnazari E, Henson M, Stebbins EG, Kerr I, O'Young G, et al. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia. 2006;20(6):1017-27. doi:10.1038/sj.leu.2404200. PMID:16617327
   PubMed Web of Science ®Google Scholar
• Obata T, Brown GE¸ Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med. 2000;28(4 Suppl):N67−77. doi:10.1097/00003246-200004001-00008. PMID:10807318
   PubMed Web of Science ®Google Scholar
• Roskoski R, Jr. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105-43. doi:10.1016/j.phrs.2012.04.005. PMID:22569528
   PubMed Web of Science ®Google Scholar
• Han X, Wang T, Zhang J, Liu X, Li Z, Wang G, Song Q, Pang D, Ouyang H, Tang X. Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFkappaB pathways. Biol Open. 2015;4(5):661-5. doi:10.1242/bio.201410900. PMID:25836672
   PubMed Web of Science ®Google Scholar